I find it difficult to understand why the company has made no announcements about approaches for artimist at this stage.
It is fair to say that the results expected from the trial will be positive and likely mirror those of the previous one. If it is as good as we are all being lead to believe and want to believe then why has one one tried to at the very least place a holding option to secure the project pending final results,
clyde as SC every given you a answer to this question which I am sure you would have asked?
- Forums
- ASX - By Stock
- phase iii trials complete - data awaited
I find it difficult to understand why the company has made no...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMS (ASX) to my watchlist
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online